IL169701A0 - The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl - Google Patents

The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl

Info

Publication number
IL169701A0
IL169701A0 IL169701A IL16970105A IL169701A0 IL 169701 A0 IL169701 A0 IL 169701A0 IL 169701 A IL169701 A IL 169701A IL 16970105 A IL16970105 A IL 16970105A IL 169701 A0 IL169701 A0 IL 169701A0
Authority
IL
Israel
Prior art keywords
fowl
humans
animals
preventing
bacterial
Prior art date
Application number
IL169701A
Original Assignee
Univ Rockefeller
New Horizons Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller, New Horizons Diagnostics Corp filed Critical Univ Rockefeller
Publication of IL169701A0 publication Critical patent/IL169701A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
IL169701A 2003-01-16 2005-07-17 The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl IL169701A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44035203P 2003-01-16 2003-01-16
PCT/US2004/001077 WO2004064732A2 (en) 2003-01-16 2004-01-16 The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl

Publications (1)

Publication Number Publication Date
IL169701A0 true IL169701A0 (en) 2007-07-04

Family

ID=32771809

Family Applications (1)

Application Number Title Priority Date Filing Date
IL169701A IL169701A0 (en) 2003-01-16 2005-07-17 The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl

Country Status (3)

Country Link
CA (1) CA2513571A1 (en)
IL (1) IL169701A0 (en)
WO (1) WO2004064732A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1817043A4 (en) * 2004-11-02 2010-01-27 Chr Hansen As Encapsulated bacteriophage formulation
MX2007014837A (en) * 2005-05-26 2008-02-21 Gangagen Life Sciences Inc Bacterial management in animal holding systems.
WO2007128348A1 (en) * 2006-05-09 2007-11-15 Inve Technologies Nv Compositions comprising lytic enzymes of bacteriophages for treating bacterial infections
AU2008275542B2 (en) * 2007-07-06 2014-06-05 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
EP3538220A1 (en) 2016-11-09 2019-09-18 Universidad Andres Bello Pharmaceutical composition based on bacteriophages against f. nucleatum; use in the treatment of diseases associated with this pathogen
RU2687488C1 (en) * 2018-07-12 2019-05-14 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" ФГБНУ ВНИТИБП Poly-strain formolated vaccine against calves pneumonia streptococcal etiology
EP3826678A4 (en) * 2018-07-25 2022-06-15 Northeastern University Selectivity screening for antimicrobial compounds
WO2020061002A1 (en) * 2018-09-18 2020-03-26 Map/Path Llc Methods and composition for controlling map infection and contamination
CN111378638B (en) * 2018-12-29 2023-05-05 江苏万邦医药科技有限公司 Helicobacter pylori phage lyase and preparation method thereof
CN110904117B (en) * 2019-10-24 2022-12-06 中国科学院遗传与发育生物学研究所 Application of plant PHL2 gene in regulation of plant seed size, dry weight and fatty acid accumulation
CN111228482B (en) * 2020-02-28 2022-06-03 衡阳师范学院 Canine parvovirus egg yolk antibody and phage composite preparation and application thereof
CN111909904B (en) * 2020-07-01 2022-04-22 青岛诺安百特生物技术有限公司 Pasteurella phage, phage composition and application thereof
CN114703152B (en) * 2022-04-25 2023-06-27 海南医学院 Bockholdele-like phage vB_ BpP _HN01 for treating meliter and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423299B1 (en) * 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
WO2001082945A2 (en) * 2000-04-28 2001-11-08 New Horizons Diagnostic Corporation The use of bacterial phage associated lysing enzymes for treating various illnesses

Also Published As

Publication number Publication date
WO2004064732A2 (en) 2004-08-05
WO2004064732A3 (en) 2006-04-20
CA2513571A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
ZA200507857B (en) Compositions for treating microbial and parasitic infections in cattle and other animals
IL172224A0 (en) Compositions for treating infection in cattle and swine
TW200507841A (en) Antibacterial agents
WO2004058144A3 (en) Antibacterial agents
EP1531828A4 (en) Methods of treating bacterial infections and diseases associated therewith
HK1072547A1 (en) Compositions and method for treating infection in cattle and swine
WO2004041210A3 (en) Antibacterial agents
AU2003290867A8 (en) Methods and products for treating staphylococcal infections
AU2003303956A8 (en) Antibacterial agents
EP1461047A4 (en) Compositions and methods for animal treatment
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
PL371081A1 (en) Pharmaceutical compound with the effect on the growth and the mineralization of osseous-skeleton system and on mature years bone and cartilage diseases among humans and animals, and method for its application
AU2002353774A1 (en) Products and methods for treating microbial infections
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
MXPA03003309A (en) Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin.
EP1510214A3 (en) 8a-azalides as veterinary antimicrobial agents
GB0323849D0 (en) Animal treatment system and method thereof
ZA200500166B (en) Methods of treating microbial infections in humans and animals
EP1631581A4 (en) Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
IL162103A0 (en) Methods of treating bacterial infections in dogs and cats
GB0517911D0 (en) Infected poultry treatment system and method thereof
AU2003276440A1 (en) Preparations comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals
GB0324742D0 (en) Improving communication with animals and/or humans lacking speaking capabilities